The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[(RS)-5-{4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione monohydrochloride] ID: ALA3526905
Cas Number: 299176-11-7
PubChem CID: 9889104
Max Phase: Preclinical
Molecular Formula: C20H20ClN3O4S
Molecular Weight: 397.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2nc(COc3ccc(CC4SC(=O)NC4=O)cc3)n(C)c2c1.Cl
Standard InChI: InChI=1S/C20H19N3O4S.ClH/c1-23-16-10-14(26-2)7-8-15(16)21-18(23)11-27-13-5-3-12(4-6-13)9-17-19(24)22-20(25)28-17;/h3-8,10,17H,9,11H2,1-2H3,(H,22,24,25);1H
Standard InChI Key: LKKAMJRUPIIUTC-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
2.3257 1.9113 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-4.0983 -0.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0971 -1.1356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3870 -1.5485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3852 0.1122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6673 -0.3047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6638 -1.1356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8724 -1.3878 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3904 -0.7126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8812 -0.0433 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.8087 0.1043 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.8085 0.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6315 0.7488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5654 -0.7078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1488 -1.4197 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6821 -1.4149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0967 -2.1265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9209 -2.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3300 -1.4046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9088 -0.6902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0860 -0.6983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1549 -1.3986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5725 -2.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2451 -2.8648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8622 -3.4124 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5736 -2.9948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3961 -2.1892 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.3297 -3.3248 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4396 -3.0432 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 6 1 0
2 11 1 0
11 12 1 0
10 13 1 0
9 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 23 1 0
26 28 2 0
24 29 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.46Molecular Weight (Monoisotopic): 397.1096AlogP: 3.06#Rotatable Bonds: 6Polar Surface Area: 82.45Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.62CX Basic pKa: 4.66CX LogP: 2.83CX LogD: 2.12Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: -0.82
References 1. Uchiyama M, Iwabuchi H, Tsuruta F, Abe K, Takahashi M, Koda H, Oguchi M, Okazaki O, Izumi T.. (2011) Pharmacokinetics, metabolism, and disposition of rivoglitazone, a novel peroxisome proliferator-activated receptor γ agonist, in rats and monkeys., 39 (4): [PMID:21177486 ] [10.1124/dmd.110.036194 ] 2. Uchiyama M, Koda H, Fischer T, Mueller J, Yamamura N, Oguchi M, Iwabuchi H, Okazaki O, Izumi T.. (2011) In vitro metabolism of rivoglitazone, a novel peroxisome proliferator-activated receptor γ agonist, in rat, monkey, and human liver microsomes and freshly isolated hepatocytes., 39 (7): [PMID:21511943 ] [10.1124/dmd.111.038729 ]